biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Some Thoughts in Summary

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Dec 23, 2022 11:52am

104 Views

Post# 35189598

RE:RE:Some Thoughts in Summary

Now on life support at .05 cents it becomes at the most a tax loss instrument now or down the road.

Just as bad is MTP which again today has an untradeable spread of 0.70 x 0.79 and a price of 0.70.

1/25th of 0.70 is 2.8¢ US.

And what are the odds that's the bottom? Not good.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China